Rockwell Automation Named Standards Recognition Entity
“Let’s imagine a fully automated production line, able to meet the demands of medical supplies, pharmaceuticals, food and other products necessary to maintain the basic lifestyle of our modern society,” wrote Rockwell Automation in a recent blog. “As input, we only supply energy and the raw materials. As output, we will have final goods. Imagine…
Baxter Granted EUAs by the FDA to Aid COVID-19 Patients
Among the many complications of a severe COVID-19 infection, as we have discovered, is acute kidney injury, or AKI. In this state, patients lose the ability to filter fluid and toxins from their blood, which if not addressed, could easily lead to loss of life. According to a joint study by Columbia University and the…
IBM Introduces AI Solution to Help Drug Researchers Develop COVID-19 Treatments Remotely
The COVID-19 pandemic has, in recent months, acted as a catalyst for arguably the most accelerated “arms race” in history for medical researchers who wish to find a vaccine — or, more realistically, therapeutic options that lessen the severity of COVID-19 especially in high-risk individuals. To maintain their haste, many medical equipment manufacturers have turned…
GE Healthcare Leveraging Lunit Technology to Expedite Covid-19 Diagnosis & Treatment
While the COVID-19 pandemic is far from over, having resurgences throughout the world following its initial outbreak, case number growth and overall death totals are largely stabilizing. As the fall rapidly approaches, health professionals concerned about a second wave are taking the opportunity to leverage tools offered by healthcare equipment manufacturers for easier identification and…
COVID-19 Impact on Lead Time Trends
Now that we are well into the COVID-19 pandemic and are beginning to see signs of reopening in the manufacturing world and beyond, we now have the ability to look at the data to determine the full impact of COVID-19 on the supply chain. For example, by analyzing the lead time trends from February through…
